Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. May 14, 2021; 27(18): 2193-2204
Published online May 14, 2021. doi: 10.3748/wjg.v27.i18.2193
Table 5 Univariate analysis of risk factors for overall early, Clavien-Dindo classification ≥ 3, and esophagojejunostomy-related complications
Variables
Early complications
CDC ≥ 3 complications
EJ-related complications

OR (95%CI)
P value
OR (95%CI)
P value
OR (95%CI)
P value
Type of surgery0.5180.4280.090
TLTG111
OTG1.202 (0.688-2.100)1.373 (0.628-3.002)3.209 (0.833–12.356)
Age0.2890.0510.035
< 60111
≥ 601.358 (0.772-2.390)2.347 (0.997-5.525)9.220 (1.164-73.022)
BMI0.0450.3800.402
< 25111
≥ 251.773 (1.012-3.109)1.419 (0.649-3.101)1.678 (0.500-5.633)
ASA score0.0300.036
1-211
33.224 (1.122-9.265)3.682 (1.088-12.456)
Number of comorbidities0.3420.752
0-211
> 21.631 (0.594-4.480)1.406 (0.170-11.599)
Combined operation0.6850.3810.735
No111
Yes0.833 (0.346-2.008)0.515 (0.117-2.272)0.697 (0.086-5.618)
History of abdominal surgery0.1300.323
No111
Yes1.640 (0.864-3.111)1.554 (0.648-3.726)1.408 (0.362-5.478)0.622
Tumor size0.5210.4420.053
< 5 cm111
≥ 5 cm0.830 (0.470-1.466)0.5210.727 (0.323-1.638)3.786 (0.983-14.585)
Operation time0.2250.6050.805
< 150 min111
≥ 150 min1.414 (0.808-2.477)1.230 (0.562-2.692)1.165 (0.347-3.912)
Retrieved lymph node0.7140.6620.246
< 30111
≥ 300.888 (0.471-1.676)1.235 (0.480-3.181)3.416 (0.429-27.170)
Pathologic tumor stage0.4180.8640.875
I111
II0.666 (0.328-1.351)1.246 (0.497-3.126)0.701 (0.138-3.568)
III0.704 (0.346-1.431)0.950 (0.348-2.592)1.119 (0.27-4.617)